Screener
Lantern Pharma LTRN Q3 2025 earnings
Reported November 12, 2025 · Before market open
EPS-$0.39Beat by $0.07
EPS estimate-$0.46
Next report
Nov 11, 2026 (in 2 months)EPS estimate-$0.35
Versus estimates
Diluted EPS
FAQ
- When did Lantern Pharma report Q3 2025 earnings?
- Lantern Pharma (LTRN) reported Q3 2025 earnings on November 12, 2025 before market open.
- What were Lantern Pharma's Q3 2025 revenue and EPS?
- Lantern Pharma reported eps of $-0.39 for Q3 2025.
- Did Lantern Pharma beat estimates in Q3 2025?
- EPS beat the consensus estimate of $-0.46 by $0.07.
- How did Lantern Pharma's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 7.1% from $-0.42.
- Where can I find Lantern Pharma's Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001493152-25-022134) and the 10-Q periodic report (0001493152-25-021927) directly on SEC EDGAR. The filing index links above go to sec.gov.
